CD8A and neoplasm: This against distal tumor mechanism can be attributed to the comprehensive activation of the immune system by the LGG-MHS + US therapeutic strategy, which was demonstrated by immunofluorescence to substantially increase the populations of infiltrating CD8+ and CD4+ T cells in distant tumor tissues (Fig. 8e and Supplementary Fig. 12e, f).